Drug-Eluting Stents: Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs

Terrence L. Trentman, David M. Rosenfeld, David R. Danielson, Susan G. Hagstrom

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Drug-eluting coronary stent use is common. Antiplatelet drug use after stent placement is necessary to prevent stent thrombosis. It has been recommended that at the time of stent placement, patients be given instructions regarding stopping antiplatelet drugs before elective surgery. Unfortunately, patients may be given inappropriate preoperative instructions by health care providers or may stop the drugs on their own. This can lead to perioperative myocardial infarctions and death. Design: Survey. Setting: Preoperative evaluation clinic of 2 teaching hospitals. Participants: One hundred sixteen patients with coronary stents completed a 13-question survey. The questionnaire assessed patient understanding of stent type and the risks of stopping antiplatelet drugs, in addition to communication among the patient, their surgeon, and their treating cardiologist before elective surgery. Intervention: None. Measurements and Main Results: The majority of patients stated either they had received no instructions from their implanting cardiologist regarding future surgery and antiplatelet drugs or they were unsure if any instructions had been given. Most patients (57%) received antiplatelet instructions regarding their planned surgery from their surgeon, whereas only 14% received instructions with (known) cardiology input. The majority of patients were unaware or unsure of any risk in prematurely stopping their antiplatelet drugs. Conclusion: Many patients are unaware of their stent type and the risks of inappropriately stopping antiplatelet drugs. Furthermore, they may have received either inappropriate preoperative instructions or no instructions at all. The opportunity exists to improve preoperative communication with patients in order to minimize perioperative thrombotic risks of coronary stents.

Original languageEnglish (US)
Pages (from-to)806-810
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume22
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

Drug-Eluting Stents
Platelet Aggregation Inhibitors
Stents
Communication
Cardiology
Teaching Hospitals
Health Personnel
Thrombosis
Myocardial Infarction

Keywords

  • antiplatelet drug
  • bare-metal stent
  • drug-eluting stent
  • perioperative myocardial infarction
  • stent thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

Drug-Eluting Stents : Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs. / Trentman, Terrence L.; Rosenfeld, David M.; Danielson, David R.; Hagstrom, Susan G.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 22, No. 6, 12.2008, p. 806-810.

Research output: Contribution to journalArticle

Trentman, Terrence L. ; Rosenfeld, David M. ; Danielson, David R. ; Hagstrom, Susan G. / Drug-Eluting Stents : Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs. In: Journal of Cardiothoracic and Vascular Anesthesia. 2008 ; Vol. 22, No. 6. pp. 806-810.
@article{cf9823d5e21240968c1344113374056a,
title = "Drug-Eluting Stents: Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs",
abstract = "Objective: Drug-eluting coronary stent use is common. Antiplatelet drug use after stent placement is necessary to prevent stent thrombosis. It has been recommended that at the time of stent placement, patients be given instructions regarding stopping antiplatelet drugs before elective surgery. Unfortunately, patients may be given inappropriate preoperative instructions by health care providers or may stop the drugs on their own. This can lead to perioperative myocardial infarctions and death. Design: Survey. Setting: Preoperative evaluation clinic of 2 teaching hospitals. Participants: One hundred sixteen patients with coronary stents completed a 13-question survey. The questionnaire assessed patient understanding of stent type and the risks of stopping antiplatelet drugs, in addition to communication among the patient, their surgeon, and their treating cardiologist before elective surgery. Intervention: None. Measurements and Main Results: The majority of patients stated either they had received no instructions from their implanting cardiologist regarding future surgery and antiplatelet drugs or they were unsure if any instructions had been given. Most patients (57{\%}) received antiplatelet instructions regarding their planned surgery from their surgeon, whereas only 14{\%} received instructions with (known) cardiology input. The majority of patients were unaware or unsure of any risk in prematurely stopping their antiplatelet drugs. Conclusion: Many patients are unaware of their stent type and the risks of inappropriately stopping antiplatelet drugs. Furthermore, they may have received either inappropriate preoperative instructions or no instructions at all. The opportunity exists to improve preoperative communication with patients in order to minimize perioperative thrombotic risks of coronary stents.",
keywords = "antiplatelet drug, bare-metal stent, drug-eluting stent, perioperative myocardial infarction, stent thrombosis",
author = "Trentman, {Terrence L.} and Rosenfeld, {David M.} and Danielson, {David R.} and Hagstrom, {Susan G.}",
year = "2008",
month = "12",
doi = "10.1053/j.jvca.2008.04.021",
language = "English (US)",
volume = "22",
pages = "806--810",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Drug-Eluting Stents

T2 - Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs

AU - Trentman, Terrence L.

AU - Rosenfeld, David M.

AU - Danielson, David R.

AU - Hagstrom, Susan G.

PY - 2008/12

Y1 - 2008/12

N2 - Objective: Drug-eluting coronary stent use is common. Antiplatelet drug use after stent placement is necessary to prevent stent thrombosis. It has been recommended that at the time of stent placement, patients be given instructions regarding stopping antiplatelet drugs before elective surgery. Unfortunately, patients may be given inappropriate preoperative instructions by health care providers or may stop the drugs on their own. This can lead to perioperative myocardial infarctions and death. Design: Survey. Setting: Preoperative evaluation clinic of 2 teaching hospitals. Participants: One hundred sixteen patients with coronary stents completed a 13-question survey. The questionnaire assessed patient understanding of stent type and the risks of stopping antiplatelet drugs, in addition to communication among the patient, their surgeon, and their treating cardiologist before elective surgery. Intervention: None. Measurements and Main Results: The majority of patients stated either they had received no instructions from their implanting cardiologist regarding future surgery and antiplatelet drugs or they were unsure if any instructions had been given. Most patients (57%) received antiplatelet instructions regarding their planned surgery from their surgeon, whereas only 14% received instructions with (known) cardiology input. The majority of patients were unaware or unsure of any risk in prematurely stopping their antiplatelet drugs. Conclusion: Many patients are unaware of their stent type and the risks of inappropriately stopping antiplatelet drugs. Furthermore, they may have received either inappropriate preoperative instructions or no instructions at all. The opportunity exists to improve preoperative communication with patients in order to minimize perioperative thrombotic risks of coronary stents.

AB - Objective: Drug-eluting coronary stent use is common. Antiplatelet drug use after stent placement is necessary to prevent stent thrombosis. It has been recommended that at the time of stent placement, patients be given instructions regarding stopping antiplatelet drugs before elective surgery. Unfortunately, patients may be given inappropriate preoperative instructions by health care providers or may stop the drugs on their own. This can lead to perioperative myocardial infarctions and death. Design: Survey. Setting: Preoperative evaluation clinic of 2 teaching hospitals. Participants: One hundred sixteen patients with coronary stents completed a 13-question survey. The questionnaire assessed patient understanding of stent type and the risks of stopping antiplatelet drugs, in addition to communication among the patient, their surgeon, and their treating cardiologist before elective surgery. Intervention: None. Measurements and Main Results: The majority of patients stated either they had received no instructions from their implanting cardiologist regarding future surgery and antiplatelet drugs or they were unsure if any instructions had been given. Most patients (57%) received antiplatelet instructions regarding their planned surgery from their surgeon, whereas only 14% received instructions with (known) cardiology input. The majority of patients were unaware or unsure of any risk in prematurely stopping their antiplatelet drugs. Conclusion: Many patients are unaware of their stent type and the risks of inappropriately stopping antiplatelet drugs. Furthermore, they may have received either inappropriate preoperative instructions or no instructions at all. The opportunity exists to improve preoperative communication with patients in order to minimize perioperative thrombotic risks of coronary stents.

KW - antiplatelet drug

KW - bare-metal stent

KW - drug-eluting stent

KW - perioperative myocardial infarction

KW - stent thrombosis

UR - http://www.scopus.com/inward/record.url?scp=56449130863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449130863&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2008.04.021

DO - 10.1053/j.jvca.2008.04.021

M3 - Article

C2 - 18834797

AN - SCOPUS:56449130863

VL - 22

SP - 806

EP - 810

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 6

ER -